HOUSTON--(BUSINESS WIRE)--Positron Corporation (OTC: POSC) (the “Company”) announced today that it has acquired an exclusive license to a coronary disease reversal and prevention practice management program created by K. Lance Gould, M.D. and the University of Texas Health Science Center at Houston.